Explore Real-Time Regulatory Intelligence

Monitor FDA alerts and clinical trial shifts across therapeutic areas — powered by AI. Stay ahead with automated summaries, direct source links, and real-time updates.

Example AI Summaries
(Preview only — data shown is fictional)

GPT Summary: Neurology

NeuroBoost received fast-track designation. Anticipated to impact prescribing patterns across early-phase Alzheimer’s studies.

GPT Summary: Dermatology

Dermalux's approval may overlap with three ongoing skin regeneration trials. Guidance updated May 2025.